These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction]. Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138 [No Abstract] [Full Text] [Related]
23. Adrenergic agents in acute asthma: valuable new alternatives. Stiell IG; Rivington RN Ann Emerg Med; 1983 Aug; 12(8):493-500. PubMed ID: 6349435 [No Abstract] [Full Text] [Related]
24. Studies on Terbulaline, a new selective bronchodilating agent. Introductory remarks. Acta Med Scand Suppl; 1970; 512():7-9. PubMed ID: 4396164 [No Abstract] [Full Text] [Related]
25. The pharmacological basis of bronchodilator therapy. Weinberger M; Hendeles L Ration Drug Ther; 1977 Jun; 11(6):1-6. PubMed ID: 882682 [No Abstract] [Full Text] [Related]
26. [Sympathomimetic drugs in the treatment of childhood asthma]. Zach M Monatsschr Kinderheilkd; 1982 Sep; 130(9):688-95. PubMed ID: 7144759 [TBL] [Abstract][Full Text] [Related]
27. [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Gillissen A; Berdel D; Buhl R; Crieé CP; Kardos P; Magnussen H; Rabe KF; Rolke M; Vogelmeier C; Worth H; Virchow JC Dtsch Med Wochenschr; 2007 Jan; 132(1-2):33-9. PubMed ID: 17187322 [No Abstract] [Full Text] [Related]
28. Treatment of asthma and bronchoconstriction. Holtzman MJ; Nadel JA Ration Drug Ther; 1981 Jun; 15(6):1-6. PubMed ID: 6819593 [No Abstract] [Full Text] [Related]
29. [Progress in the symptomatic treatment of bronchial asthma]. Jäger L Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):231-45. PubMed ID: 4403663 [No Abstract] [Full Text] [Related]
31. Experiences of longterm treatment of asthma with terbutaline. A study on frequency of side effects and therapeutic effect. Formgren H Acta Allergol; 1971 Apr; 26(2):81-9. PubMed ID: 5109840 [No Abstract] [Full Text] [Related]
32. Assessment of bronchodilator drugs on asthmatic out-patients by daily measurements of the peak expiratory flow rate. Heaf PJ; Mattila MJ Arzneimittelforschung; 1969 Dec; 19(12):1927-9. PubMed ID: 4908261 [No Abstract] [Full Text] [Related]
33. [Asthma drug combination tested by body plethysmography]. Schindl R Wien Med Wochenschr; 1972 Jan; 122(5):68-71. PubMed ID: 5059859 [No Abstract] [Full Text] [Related]
34. [Broncholytica]. Vale JR Tidsskr Nor Laegeforen; 1975 Jan; 95(3):188-90. PubMed ID: 1118843 [No Abstract] [Full Text] [Related]
35. [Evidence to the treatment of asthma]. Lahdensuo A Duodecim; 2000; 116(22):2449-50. PubMed ID: 12053336 [No Abstract] [Full Text] [Related]
36. Drug treatment in bronchial asthma. Blumstein CG Semin Drug Treat; 1973; 2(4):385-401. PubMed ID: 4581867 [No Abstract] [Full Text] [Related]
37. Sympathomimetic bronchodilators and animal models for assessing their potential value in asthma. Bowman WC; Raper C J Pharm Pharmacol; 1976 Apr; 28(4 SUPPL):369-74. PubMed ID: 6741 [No Abstract] [Full Text] [Related]
38. [Side effects in treating asthma with sympathomimetic drugs in aerosol dosages]. Liljestrand A Lakartidningen; 1969 Dec; 66():Suppl IV:93+. PubMed ID: 5400774 [No Abstract] [Full Text] [Related]
39. [Special conditions in the treatment of bronchial asthma in children]. Antonsen BJ Tidsskr Nor Laegeforen; 1973 Sep; 93(27):2032-5. PubMed ID: 4766382 [No Abstract] [Full Text] [Related]